Label Changes for:
Vfend (voriconazole) for Oral Suspension
May 2008
Changes have been made to the PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- May 2008
| The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. |
Sections Modified
PRECAUTIONS
- Drug Interactions
- Table 12: Effect of Voriconazole on Pharmacokinetics of Other Drugs
- Alfentanil (CYP3A4 Inhibition)
- Table 12: Effect of Voriconazole on Pharmacokinetics of Other Drugs
Label approved 05/30/2008 is not available on Drugs@FDA
